Interestingly, while both models exhibited defects in line with patient data, we identified previously unreported features for CHARGE syndrome, including reduced levels of insulin, which could potentially be tested as a new biomarker for CHARGE syndrome. The gene discussed is INS; the disease is CHARGE syndrome.